Turtle-associated salmonellosis (TAS) in humans has been a concern of public health officials since the 1960's. The 
Introduction
Salmonella Newport was first isolated from a chelonian, Geochelone giganteas, by McNeil and Hinshaw in 1946 . It wasn't until almost seven years later that the first case of turtle-associated salmonellosis (TAS) in a human was reported (Boycott, et al, 1953) . The apparent incidence of TAS continued to increase over the next two decades (Williams and Heldson, 1965) . The public health concern for TAS during this period was limited, but would change with the increased incidence of cases reported in young children. The first case of TAS in a child was reported in 1963 (Hersey and Mason, 1963) . Salmonella Hartford was recovered from a 7-month old infant with diarrhea, vomiting, and fever. An investigation of the infant's environment resulted in the isolation of the same serotype from the family's pet turtle.
The increased incidence of TAS in children during the late 1960's and early 1970's became an important concern to both state and federal health officials. In 1972, the Food and Drug Administration required certification verifying Salmonella-free status for the interstate transport of pet turtles. This program was found to be ineffective. A study conducted by the Center for Disease Control concluded that 38% of the animals certified to be Salmonellafree were contaminated (CDC, 1974) . Therefore, in 1975 , the Food and Drug Administration restricted the intraand interstate sales of all turtle eggs and live turtles with a carapace length less than 10.2-cm. The decision to restrict the sale of turtles with a carapace length less than 10.2-cm was based on the assumption that these animals would be less desirable to young children. Enforcement of this policy resulted in a 77% reduction in the incidence of cases in those states not producing turtles (Cohen, et al, 1980) . Exceptions to this 1975 law were made for marine turtles and educational and scientific institutions. Violators of this law are provided a written demand to destroy the animals under FDA supervision within 10 days. Violators are also subject to a fine not more than $1000 and/or imprisonment of not more than one year for each violation. Herpetoculturists that breed exotic chelonians have avoided prosecution by selling animals under the guise of educational animals.
Currently, there are several hundred reptile swap meets a year in the U.S. where chelonians with a carapace length less than 10.2-cm can be purchased. In addition, chelonians less than 10.2-cm in length are routinely sold via the internet. The availability of these chelonians, in combination with the apparent public health concern for TAS, suggest that there is a need to develop methods to minimize Salmonella spp. in the chelonians or their environment to minimize the health risks associated with pet reptile ownership.
Attempts to reduce or eliminate Salmonella spp. in turtles with antimicrobials were initiated after the FDA regulation was implemented in 1975.
Treatment of hatchlings with oxytetracycline in their tank water for up to 14 days alleviated shedding in treated turtles, but did not affect systemic infection (Siebling, et al, 1975) . Treatment of the freshly laid eggs with oxytetracycline or chloramphenicol with a temperature differential egg dip method was also successful at eliminating Salmonella spp. in eggs less than one day old, but did not clear eggs greater than two days old (Siebling, et al, 1975) . Large-scale experimentation on commercial turtle farms with surface decontamination and pressure or temperature differential treatment of eggs with gentamicin dip solutions for eggs greater than 2 days old, followed by hatching the eggs on Salmonella-free bedding, substantially reduced Salmonella sp. infections and shedding rates in hatchling turtles (Siebling, et al, 1984) . Forty percent of the eggs not treated with the gentamicin were found to harbor Salmonella sp., positive (D'Aoust, et al , 1990) . Of the 37 Salmonella strains isolated, 30 (81%) were gentamicin resistant (D'Aoust, et al, 1990) . Similar results have been reported from samples collected directly from the farms in Louisiana. Shane et al. (1990) collected environmental samples and live hatchlings directly from two Louisiana turtle farms. Isolates of S. Arizonae and S. Poona collected from turtles at one of the farms were resistant to erythromycin, gentamicin, tetracycline, and sulfonamide. Pond water samples from both farms showed similar antimicrobial resistant patterns to erythromycin. In 1988, 115 batches of turtle hatchlings were submitted from 28 farms to the Louisiana Department of Agriculture and Forestry for analysis (Shane, et al, 1990) . Five (4.3%) Salmonella isolates were obtained.
Four of the organisms were submitted for serotyping; three were S. Arizona and one was S. Poona. All four isolates were resistant to erythromycin, gentamicin, tetracycline, and sulfonamide. The findings of these studies suggest that the application of a single intervention, such as egg washing, will not be sufficient to suppress or eliminate Salmonella sp. from captive bred chelonians.
To successfully manage Salmonella sp. in chelonians, a series of interventions will be necessary. A methodical approach comprised of treatment interventions that reduce Salmonella sp. in adult breeding chelonians, reduce Salmonella sp. contamination of the egg, reduce Salmonella sp. colonization of the hatchling, and reduce Salmonella sp. dissemination in the environment are required. Each of these management schemes will require extensive research.
The purpose of this research was to evaluate a specific method of reducing Salmonella sp. in the environment of hatchling chelonians.
Polyhexamethylene biguanide is a sanitizing agent that is considered safe for human and animal use. This compound has been used as a mouth rinse for humans (Rosin, et al, 2001 ), a microbicide for chicken eggs (Cox, et al, 1994) , and a treatment for protozoal fungal keratitis (Panda, et al, 2003) . The antimicrobial effect of this compound varies with concentration, being bacteriostatic at low concentrations and bacteriocidal at higher concentrations.
There are many different derivatives of polyhexamethylene biguanide. One such derivative, Baquacil® (poly-iminoimidocarbonylimino-hexamethylene hydro chloride)(Avecia Inc., Wilmington, DE 19850 USA) , is a commercial swimming pool sanitizer and algistat. This product is used as a safe alternative to chlorine for swimming pools. Because Baquacil® is considered safe for humans, its application as a microbicide may prove useful for captive chelonians.
The primary objective of this study was to determine if Baquacil® would suppress or eliminate Salmonella sp. in the aquatic habitat of the RES. The specific hypotheses being tested were:
1. Salmonella sp. is less likely to be isolated from water samples collected from RES habitats with Baquacil® than from those without Baquacil®.
2. There will be no difference in the Salmonella sp. status of water samples collected from water treated with 25 or 50 ppm Baquacil®.
3. There will be no difference in the prevalence of (intestinal) Salmonella sp. between treatment (Baquacil®) and control (no Baquacil®) groups at necropsy.
4. There will be no difference in the frequency of Salmonella sp. positive cultures between the original and delayed secondary enrichment samples.
Materials and Methods
This study was conducted in accordance with the regulations specified by the Louisiana State University Institutional Animal Care and Use Committee (03-004). Fifty-five hatchling Salmonella-positive RES were used for this study. The RES were housed in individual plastic containers with approximately 1 liter of chlorinated water or a dechlorinated water and Baquacil® (25 or 50 ppm) solution. The RES were randomly assigned to three different treatment groups using a random generator: Group 1) 25 ppm Baquacil® (n=20), Group 2) 50 ppm Baquacil® (n=20), and Group 3) chlorinated tap water (n=15). Baquacil® concentration, water pH, and alkalinity were determined using Aquachek pool The pH of the water was adjusted to 7.5 and the alkalinity maintained between 80-120 ppm. The water from the enclosures was changed weekly, and fresh Baquacil® solution was made weekly. The RES were offered a Salmonella-free commercial turtle pellet food (Fluker Farms, Port Allen, LA 70767) daily.
Water samples were collected three times a week for four weeks and evaluated for Salmonella sp. using standard microbiological techniques. A total of 3-ml of water was collected from the center of the enclosure, where organic material accumulated, and added to 7-ml of selenite enrichment broth. The A 96-hour delayed secondary enrichment (DSE) was performed on all of the samples to increase the likelihood of identifying samples with low concentrations of Salmonella sp.. The original selenite samples were placed at room temperature for 96 hours. A 3-ml aliquot of the original selenite sample was added to 7-ml of selenite enrichment broth and incubated aerobically at 37 o C for 48 hours. The samples were processed using the techniques described previously.
At the conclusion of the 4-week trial, the RES were humanely euthanized using an overdose of a barbiturate (0.05 ml/turtle, intracardiac)(Beuthanasia, Schering Plough Animal Health Care, Union NJ 07083). A gross necropsy was performed using sterile techniques. Scissors were used to cut the bridge of the shell and facilitate the removal of the plastron. The gastrointestinal tract was excised, placed into 7-ml of selenite broth, and vortexed to macerate the tissues.
The samples were incubated aerobically at 37 o C for 48 hours, and the samples processed using the techniques described previously. A 96-hour delayed secondary enrichment was also performed with the necropsy specimens. The carcasses of the RES from the control group and the 50 ppm Baquacil® group were placed into 10% neutral buffered formalin and submitted for histopathology.
Tissue samples, including sections of the skin and carapace, the eyes, conjunctiva, and oral mucosa, were taken from six randomly selected RES from the control group and from six turtles in the 50 ppm Baquacil® treatment group.
The tissues were processed routinely, sectioned (4 µm thickness), stained with hematoxylin and eosin, and examined microscopically.
The sample size required for this study was calculated under the following assumptions and criteria: that the proportion of Salmonella-positive RES in the control group would be > 0.7, and that the proportion of Salmonella-positive RES in the Baquacil group would be < 0.2, that the α = 0.05, and the power = 0.89. The 95% binomial confidence intervals (CI) were calculated for each of the proportion estimates. In cases where the prevalence estimate was 0, the 95% confidence intervals were calculated with the technique described by van Belle and Millard (1998) Values of p< 0.05 were considered statistically different. Statistical analysis was performed using SPSS 11.0 (SPSS, Inc., Chicago, IL 60606).
Results
Salmonella sp. was detected in the water column from each group at least once during the study (Table 1) . Only one RES in the control group was Salmonella sp. positive on every culture. There was a significant within-groups difference over time (Cochran's Q: 138.2, p<0.001). The prevalence of Salmonella sp. in the water column of the control RES sliders was significantly higher than in the treatment groups (Figure 1 ). There was no difference in the Salmonella-status (95% CI) of RES between the 25 and 50 ppm treatment groups, nor was there an apparent difference based on the day of week (95% CI) the sample was collected. There was no significant difference (p=0.8) in the Salmonella-status of the RES from the three treatment groups at necropsy Interestingly, the frequency of DSE culture-positive only samples was greatest in the 50 (36%, 5/14) and 25 (29%, 5/17) ppm treatment groups.
Histologically, the eyes, corneas, eyelids, tongue, oral mucosa, skin, and carapace of the 50 ppm Baquacil® treated RES were no different than those of the control group. In both groups, the eyelids and corneas were uniformly thick with normal epithelial cells and no evidence of degeneration, erosion or inflammation. Internal ocular structures were within normal limits. Likewise, the oral mucosa, tongue, skin, and carapace and underlying structures were normal in both groups.
Discussion
The propagation of Salmonella-free chelonians is a primary objective for chelonian producers, and is a concern of public health officials. Currently, chelonian eggs are sanitized using a combination of washing with water or sodium hypochlorite solution and temperature or pressure differential treatment using gentamicin. Although the apparent prevalence of Salmonella sp. in these eggs is very low, occasional cases of antimicrobial resistant Salmonella sp. are reported (D 'Aoust, et al, 1990; Shane, et al, 1990) . In addition, once the chelonians are removed from a "clean environment" and disseminated into the pet retail trade, the industry has no control method in place to prevent the recolonization of a chelonian or suppress/eliminate shedding in Salmonella-positive chelonians.
Polyhexamethylene biguanide has been found to be effective at eliminating experimentally inoculated Salmonella Typhimurium from the surface of chicken eggs. In a study to evaluate the efficacy of several different microbicides, including quaternary ammonium, peroxygen compounds, hydrogen peroxide, ethylene oxide, phenols, and sodium and potassium hydroxide, only the polyhexamethylene biguanide (0.035%, Cosmocil CQ, ICI Americas, Inc., Wilmington, DE 19897) product was 100% effective at eliminating the salmonellae (Cox,et al, 1994) . The results of this study also indicate that polyhexamethylene biguanide products have some effect against reptile serotypes too. The variable prevalence of Salmonella sp. in these RES, especially the control group, was not unexpected. Transient shedding of Salmonella sp. has been documented previously in reptiles (Mitchell, 2001) . Inappropriate environmental conditions and other causes of physiologic stress may increase the rate of shedding. Historically, the management of RES in captivity was unacceptable. The public health concern identified in the 1960's and 1970's was likely the result of a limited understanding of the husbandry requirements of these animals. In the case of this study, even though the RES were housed in simple enclosures, the prevalence of Salmonella sp. in the water column never approached 100%. These finding suggest that, even in the control group, that the risk of contracting TAS is not constant. Providing an appropriate environment and diet, in addition to using a sanitizing agent such as Baquacil®, may reduce the zoonotic health risk associated with these reptiles.
Because the purpose of this study was to determine the prevalence of Salmonella sp. in the habitats of RES at given time points, an enrichment broth and DSE were used to increase the likelihood of isolating the organism. There was no significant difference in the Salmonella status of the RES at necropsy. The similar prevalence of Salmonella between the three RES groups suggests that Baquacil® has no effect on the colonization of Salmonella in these animals. However, it was interesting to note that a percentage (control: 20%, 25 ppm: 30%, 50 ppm: 25%) of these turtles were Salmonella-negative at the time of the necropsy. This finding may have been the result of using microbiological culture as the method of detection. Mitchell (2001) estimated the sensitivity of microbiological culture as a method of detecting Salmonella sp. in green iguanas (Iguana iguana) to be approximately 70%. This would suggest that approximately 3/10 positive samples could be misclassified as false negative samples. In addition, if these animals were harboring low numbers of salmonellae, the assay could have been insufficient to detect them. However, DSE was used to increase the likelihood of detecting low numbers of Salmonella sp.. Another possible explanation for this finding is that the RES could have self-cleared the Salmonella sp.. Salmonella sp. infections and carrier states are generally considered to be self-limiting in mammals, and persistent in reptiles. Based on these findings, this may not be the case, and some reptiles may also self-clear or not remain colonized.
Attempts to isolate
There were no significant histologic lesions in the RES treated with 50 ppm Baquacil®. The high dose (50 ppm) used for this study is similar to that recommended for the treatment of swimming pools and is lower than that used to treat experimental fungal keratitis in rabbits (Panda, et al, 2003) . Because the gastrointestinal tracts were removed from these animals for culture, we were unable to evaluate them for pathologic changes. However, the eyes, palpebrae, oral cavity, skin and shell were evaluated and lacked microscopic evidence of damage. Future studies should evaluate longer-term exposure to Baquacil® and complete necropsies should be performed to determine if there are any pathologic lesions associated with the ingestion of Baquacil® treated water.
Conclusions
The results of this study are promising and serve as an initial step in the development of an intervention plan for the management of Salmonella-positive chelonians. Additional long-term studies to evaluate the effects of this compound in different species of chelonians and on specific reptile Salmonella serotypes should be pursued. In addition, studies to evaluate the potential for the development of resistance to Baquacil® need to be pursued.
